Alphatec Spine to Showcase Comprehensive Product Portfolio at the Upcoming 28th Annual North American Spine Society (NASS)

Alphatec Spine to Showcase Comprehensive Product Portfolio at the Upcoming
28th Annual North American Spine Society (NASS) Meeting in New Orleans,
Louisiana

CARLSBAD, Calif., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device
company that provides physician-inspired solutions for patients with spinal
disorders, announced today that it will showcase several new products at the
upcoming North American Spine Society (NASS) meeting in New Orleans, LA, which
will be held from October 9th – 12th, 2013. Alphatec Spine will be located in
booth number 631.

This year's product showcase will include:

ILLICO® Multi-Level (ML) Minimally Invasive Surgery System (MIS) is Alphatec
Spine's simple, secure and highly versatile solution for minimally invasive
posterior fixation for addressing instability in the thoracic and lumbar
spine. With the ILLICO ML system surgeons are able to address complex
multi-level spinal trauma and deformities and therefore ensure reliable
reproducible results, which are designed to minimize pain and help speed
recovery for their patients. This system features the minimally invasive
ILLICO MIS Posterior Fixation System and the ILLICO FS Facet Fixation screws.

Alphatec NEXoss™ Nanostructure BA Matrix is a next-generation synthetic bone
graft that provides the optimal microenvironment to support reliable,
consistent bone growth for patients during the healing process. Alphatec
NEXoss is comprised of an innovative bioactive scaffold engineered to support
successful posterolateral fusions through two unique patented technologies
that work in tandem: a unique collagen biopolymer that contributes to bone
growth and nanostructure hydroxyapatite (HA) crystals that mimic natural bone
composition, structure and size.

Pegasus™ Anchored Cervical Interbody System is the Company's newest anchored,
cervical interbody device that provides surgeons with a simplified approach to
ACDF procedures. Pegasus provides the delivery of a spacer with an integrated
anchoring mechanism in a single-step, non-impaction implantation, which is
designed to reduce operative time. The controlled anchor deployment provides
surgeons confidence and simple intra-operative and post-operative removal if
needed.

Alphatec Solus™ Anterior Lumbar Interbody Fusion Device is the latest
innovative solution designed to provide fast, easy and effective stabilization
for ALIF procedures using a single-step process thereby benefitting both
surgeons and patients. Alphatec Solus delivers four points of fixation that
are deployed simultaneously while providing substantial space to insert bone
graft to help promote rapid fusion at the site, all of which are designed to
increase fixation and decrease operative time.

"With our focus on physician-inspired solutions we are very excited to be able
to join researchers, key thought leaders, and physicians at the 28^th annual
NASS meeting this month to discuss innovations in the field of spinal
disorders and related conditions that can help lead to promising new
therapeutic options for patients," said Les Cross, Chairman and CEO of
Alphatec Spine. "We look forward to  demonstrating the unique value and
benefits of our broad portfolio of complementary products that help play a
role in enabling patients to regain their active lifestyles and live better
lives."

In addition, on Thursday, October 10th at 5:30 pm, Alphatec Spine is hosting
an educational symposium featuring renowned thought leaders Dr. Antonio
Castellvi, M.D., Dr. Boyle Cheng, PhD. and Dr. Celeste Abjornson, PhD. These
distinguished professionals will be speaking about key topics in the
prevention and treatment of spinal injuries and related conditions, including
minimally invasive techniques for multi-level constructs with ILLICO, results
of a biomechanical study of the NOVEL® ALIF device with integrated fixation
and next-generation bone grafting solutions. The Company will also offer
interactive sawbones workshops at its booth during exhibit hours.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is
a medical device company that designs, develops, manufactures and markets
physician-inspired products and solutions for the treatment of spinal
disorders associated with trauma, congenital deformities, disease and
degeneration. The Company's mission is to combine innovative surgical
solutions with world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in the U.S.
and in over 50 countries internationally via a direct sales force and
independent distributors.

Additional information can be found at www.alphatecspine.com.

Forward Looking Statements

This press release may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current expectations
and are subject to a number of risks and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no assurance
that actual results or business conditions will not differ materially from
those projected or suggested in such forward-looking statements as a result of
various factors. Forward-looking statements include references to the
Company's belief that certain of its products offer competitive
functionalities in the marketplace. In addition, forward-looking statements
include the Company's ability to develop and commercialize new products,
including the products discussed in this press release. The words "believe,"
"will," "should," "expect," "intend," "estimate" and "anticipate," variations
of such words and similar expressions identify forward-looking statements, but
their absence does not mean that a statement is not a forward-looking
statement. The important factors that could cause actual operating results to
differ significantly from those expressed or implied by such forward-looking
statements include, but are not limited to; the uncertainty of success in
developing or acquiring and commercializing new products or product
technologies; acceptance of Alphatec Spine's products by the surgeon
community, including the products discussed in this press release; Alphatec
Spine's ability to develop and expand its U.S. and/or global revenues;
continuation of favorable third part payor reimbursement for procedures
performed using Alphatec Spine's products, including the products discussed in
this press release; unanticipated expenses or liabilities or other adverse
events affecting cash flow or Alphatec Spine's ability to successfully control
its costs or achieve profitability; uncertainty of additional funding;
Alphatec Spine's ability to compete with other competing products and with
emerging new technologies; product liability exposure; patent infringement
claims and claims related to Alphatec Spine's intellectual property. Please
refer to the risks detailed from time to time in Alphatec Spine's SEC reports,
including its Annual Report Form 10-K, as well as other filings on Form 10-Q
and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise, unless required by
law.

CONTACT: Investor/Media Contact:
        
         Christine Zedelmayer
         Investor Relations
         Alphatec Spine, Inc.
         (760) 494-6610
         czedelmayer@alphatecspine.com

Alphatec Spine
 
Press spacebar to pause and continue. Press esc to stop.